Clinical Trials Logo
  1. Home
  2. Lassa Fever
  3. NCT04093076

Dose-ranging Study: Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers in Ghana

Lassa Fever Clinical Trial

Official title:
Dose-Ranging Study to Evaluate the Safety, Tolerability and Immunogenicity of INO-4500 in Combination With Electroporation in Healthy Volunteers in Ghana

Clinical Trial Summary

This is a randomized, blinded, placebo-controlled trial to evaluate the safety, tolerability and immunological profile of INO-4500 administered by intradermal (ID) injection followed by electroporation (EP) using CELLECTRA™ 2000 device in healthy volunteers in Ghana.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04093076
Study type Interventional
Source Inovio Pharmaceuticals
Contact
Status Completed
Phase Phase 1
Start date January 27, 2021
Completion date October 14, 2022
View Details
See also
  Status Clinical Trial Phase
Withdrawn NCT00992693 - Treatment of Viral Hemorrhagic Fevers With Intravenous Ribavirin in Military Treatment Facilities Phase 2
Completed NCT04285034 - Cardiovascular Function and Ribavirin PK/PD in Lassa Fever in Lassa Fever
Completed NCT03805984 - Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers Phase 1
Recruiting NCT05868733 - A Lassa Fever Vaccine Trial in Adults and Children Residing in West Africa Phase 2
Terminated NCT03889106 - Cardiovascular Function and Ribavirin Pharmacokinetics and Pharmacodynamics in Patients With Lassa Fever
Active, not recruiting NCT04794218 - A Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-LASV-GPC Vaccine in Adults in Good General Heath Phase 1
Completed NCT04907682 - Pharmacokinetics, Tolerability and Safety of Favipiravir Compared to Ribavirin for the Treatment of Lassa Fever Phase 2
Not yet recruiting NCT06212336 - ISTH/ANRS 0409s INTEGRATE Lassa Fever Study Phase 2/Phase 3
Not yet recruiting NCT06222723 - LAssa Fever Adjunct Treatment With DEXamethasone Phase 2
Recruiting NCT03655561 - Lassa Fever Clinical Course and Prognostic Factors in Nigeria